Frontiers Current Pharmacological Strategies for Duchenne

Optimized lentiviral vector to restore full-length dystrophin via a cell-mediated approach in a mouse model of Duchenne muscular dystrophy: Molecular Therapy - Methods & Clinical Development

Pharmacological strategies for muscular dystrophy

Advancing Precision Medicine in Paediatrics: Past, present and future, Cambridge Prisms: Precision Medicine

Frontiers Drug Screening and Drug Repositioning as Promising Therapeutic Approaches for Spinal Muscular Atrophy Treatment

Role of CRISPR/Cas9 in the treatment of Duchenne muscular dystrophy and its delivery strategies - ScienceDirect

EMA starts review of Italfarmaco's Duchenne drug

Duchenne muscular dystrophy: Major trials to watch in 2023

PDF) Therapeutic Strategies for Dystrophin Replacement in Duchenne Muscular Dystrophy

Frontiers Drug development progress in duchenne muscular dystrophy